<?xml version="1.0" encoding="utf-8" ?><rss version="2.0"><channel><title>Bing: Drug Testing Process Flowchart</title><link>http://www.bing.com:80/search?q=Drug+Testing+Process+Flowchart</link><description>Search results</description><image><url>http://www.bing.com:80/s/a/rsslogo.gif</url><title>Drug Testing Process Flowchart</title><link>http://www.bing.com:80/search?q=Drug+Testing+Process+Flowchart</link></image><copyright>Copyright © 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>Drugs (psychoactive) - World Health Organization (WHO)</title><link>https://www.who.int/health-topics/drugs-psychoactive</link><description>The use of psychoactive drugs without medical supervision is associated with significant health risks and can lead to the development of drug use disorders. Drug use disorders, particularly when untreated, increase morbidity and mortality risks for individuals, can trigger substantial suffering and lead to impairment in personal, family, social, educational, occupational or other important ...</description><pubDate>Tue, 14 Apr 2026 04:56:00 GMT</pubDate></item><item><title>WHO Drug Information</title><link>https://www.who.int/our-work/access-to-medicines-and-health-products/who-drug-information</link><description>About WHO Drug Information WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of health professionals and policy makers. Launched in 1987, WHO Drug Information communicates the latest international news and trends to regulatory agencies, academic and training institutions, researchers ...</description><pubDate>Sun, 29 Mar 2026 04:24:00 GMT</pubDate></item><item><title>Alcohol, Drugs and Addictive Behaviours</title><link>https://www.who.int/teams/mental-health-and-substance-use/alcohol-drugs-and-addictive-behaviours/drugs-psychoactive</link><description>The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed policies, strategies and interventions to reduce the burden associated with alcohol, drugs and addictive behaviours.</description><pubDate>Thu, 09 Apr 2026 07:39:00 GMT</pubDate></item><item><title>Over 3 million annual deaths due to alcohol and drug use, majority ...</title><link>https://www.who.int/news/item/25-06-2024-over-3-million-annual-deaths-due-to-alcohol-and-drug-use-majority-among-men/</link><description>A new report from the World Health Organization (WHO) highlights that 2.6 million deaths per year were attributable to alcohol consumption, accounting for 4.7% of all deaths, and 0.6 million deaths to psychoactive drug use. Notably, 2 million of alcohol and 0.4 million of drug-attributable deaths were among men.</description><pubDate>Thu, 09 Apr 2026 05:44:00 GMT</pubDate></item><item><title>WHO announces landmark changes in treatment of drug-resistant tuberculosis</title><link>https://www.who.int/news/item/15-04-2025-who-announces-landmark-changes-in-treatment-of-drug-resistant-tuberculosis</link><description>The World Health Organization (WHO) today released its Consolidated guidelines on tuberculosis (TB)- Module 4: treatment and care, consolidating all previous guidelines into a single comprehensive document and introducing significant improvements in treatment options for people with multidrug-resistant or rifampicin-resistant tuberculosis (MDR/RR-TB).</description><pubDate>Thu, 02 Apr 2026 20:33:00 GMT</pubDate></item><item><title>Medicines - World Health Organization (WHO)</title><link>https://www.who.int/health-topics/medicines</link><description>Access to appropriate medications is shown to have substantial impacts on community health and the related economic indicators. Quality-assured, safe and effective medicines, vaccines and medical devices are fundamental to a functioning health system.</description><pubDate>Fri, 27 Mar 2026 21:09:00 GMT</pubDate></item><item><title>WHO launches new framework to tackle drug resistance to HIV, hepatitis ...</title><link>https://www.who.int/news/item/24-11-2025-who-launches-new-framework-to-tackle-drug-resistance-to-hiv-hepatitis-b-and-c-and-stis</link><description>WHO has released the Integrated drug resistance action framework for HIV, hepatitis B and C and sexually transmitted infections, 2026–2030, a landmark roadmap to address the growing threat of drug resistance and safeguard progress toward ending AIDS and the epidemics of hepatitis B, hepatitis C and sexually transmitted infections (STIs) as public health concerns.</description><pubDate>Wed, 11 Mar 2026 04:03:00 GMT</pubDate></item><item><title>Anatomical Therapeutic Chemical (ATC) Classification</title><link>https://www.who.int/tools/atc-ddd-toolkit/atc-classification</link><description>In the Anatomical Therapeutic Chemical (ATC) classification system, the active substances are divided into different groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties. Drugs are classified in groups at five different levels.</description><pubDate>Wed, 08 Apr 2026 20:12:00 GMT</pubDate></item><item><title>WHO updates guidelines on opioid dependence treatment and overdose ...</title><link>https://www.who.int/news/item/09-02-2025-who-updates-guidelines-on-opioid-dependence-treatment-and-overdose-prevention</link><description>WHO announces development of updated guidelines for the psychosocially assisted pharmacological treatment of opioid dependence and community management of opioid overdoseIn 2022, approximately 60 million people globally engaged in non-medical opioid use, including the use of drugs like heroin, morphine, codeine, fentanyl, methadone, tramadol, and other similar substances. Their regular non ...</description><pubDate>Mon, 23 Mar 2026 20:52:00 GMT</pubDate></item><item><title>WHO issues global guideline on the use of GLP-1 medicines in treating ...</title><link>https://www.who.int/news/item/01-12-2025-who-issues-global-guideline-on-the-use-of-glp-1-medicines-in-treating-obesity</link><description>To address the growing global health challenge of obesity, which affects more than 1 billion people, WHO has released its first guideline on the use of Glucagon-Like Peptide-1 (GLP-1) therapies for treating obesity as a chronic, relapsing disease.</description><pubDate>Mon, 13 Apr 2026 20:56:00 GMT</pubDate></item></channel></rss>